6 July 2022 - Senate Democrats’ latest bill to lower prescription drug prices removes a provision to cap patients’ insulin costs at $35 per month, legislation that comes amid a push for a separate bipartisan bill on insulin.
Capping out of pocket insulin costs at $35 per month has been a high profile selling point for Democrats’ economic package and has been touted by President Biden, so removing it carries some risk.